Advertisement

Topics

FDA Warns About Triamcinolone and Moxifloxacin Combo for Eye

15:26 EDT 28 Jul 2017 | Medscape

The FDA issued a safety alert after serious adverse events were reported in at least 43 patients who received a compounded triamcinolone and moxifloxacin product by intravitreal injection.
News Alerts

Original Article: FDA Warns About Triamcinolone and Moxifloxacin Combo for Eye

NEXT ARTICLE

More From BioPortfolio on "FDA Warns About Triamcinolone and Moxifloxacin Combo for Eye"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...